← Markets

The Travelers Companies, Inc.

TRV · NYSE

Market open$364.30$26.49 (+7.84%)

Key statistics

Previous close$337.82
Open$342.66
Day high$367.73
Day low$342.66
52-week high$367.90
52-week low$252.26
Market cap77.47B
Volume1.92M
Average volume1.70M
P/E ratio10.88
Forward P/E—
EPS33.49
Dividend yield+1.25%

Market context

Why it moved

Travelers Companies surged sharply after reporting Q2 2026 earnings that massively beat analyst EPS expectations — posting $10.04 per share versus the consensus estimate of around $5.36–$5.41 — representing a roughly 86% earnings beat that drove strong investor enthusiasm.

TruthsandnewsStockstoryTipranksYoutubeFacebook

What is happening

Recent company-specific developments and publisher coverage.

July 17, 2026The Travelers Companies surged to a fresh 52-week high after delivering a stunning Q2 2026 earnings beat, with core EPS of $10.04 nearly doubling the FactSet consensus of $5.41 — an 86% beat. Net income jumped 46% year over year to $2.21 billion, driven by catastrophe losses plunging to $518 million from $927 million in Q2 2025, a dramatically improved combined ratio of 83.6%, 14% growth in net investment income, and strong underwriting performance across all three business segments. CEO Alan Schnitzer credited disciplined risk selection and reaffirmed a 'no price cuts to chase growth' stance, while the company returned over $1.5 billion to shareholders via buybacks.

7.9865

July 17, 2026Travelers Companies gained over 2.6% ahead of its Q2 2026 earnings release scheduled for pre-market July 17, with investors positioning ahead of results as analysts estimate revenue of $10.99B and EPS of $5.25. JPMorgan raised its price target to $341 from $322 while maintaining a Neutral rating, and Keefe, Bruyette & Woods lifted its target to $356. The broader financial sector provided a tailwind, with XLF near 52-week highs, while Travelers' strong Q1 beat—EPS of $7.71 vs. $6.80 estimated—reinforced confidence in its underwriting discipline.

2.6216

July 16, 2026Travelers Companies fell ahead of its Q2 earnings report due July 17, as investors weighed a mixed analyst backdrop and sector headwinds. TD Cowen downgraded the stock to Sell with a $297 target, while Evercore ISI cut it to In-Line citing valuation, even as Piper Sandler raised its price target to $389 and maintained Overweight. Analysts expect Q2 EPS of ~$5.33, down sharply from $6.51 a year ago, with catastrophe losses and softening commercial pricing in focus. Peer Progressive's recent earnings miss on a deteriorating combined ratio also weighed on P&C insurer sentiment broadly.

-2.2682

July 15, 2026Travelers Companies closed modestly lower as investors positioned ahead of its Q2 2026 earnings report scheduled for pre-market on July 17. Sector headwinds weighed on the stock, with peer Progressive declining over 3% after reporting a higher combined ratio and elevated catastrophe losses—raising investor concerns about industrywide underwriting profitability. RBC Capital Markets flagged softer primary property pricing and potentially elevated Q2 catastrophe losses across P&C insurers, while Piper Sandler reiterated an Overweight rating with a $340 price target, highlighting Travelers' diversified portfolio and scale as buffers against commercial market softening. The XLF financials ETF also closed lower amid broader sector pressure.

-1.3704

July 14, 2026Travelers Companies edged higher on Monday, outperforming a broader market weighed down by renewed U.S.-Iran hostilities and a tech selloff, as investor focus shifts squarely to its Q2 earnings report due July 17. Piper Sandler highlighted TRV as its weekly focus idea ahead of results, reiterating an Overweight rating and $340 price target, citing expected margin improvement in Personal Insurance and resilience versus peers amid commercial pricing deceleration. The bullish setup is reinforced by a fresh AM Best report noting the U.S. P&C sector posted its strongest performance in a decade in 2025, while Truist's Buy initiation at $395 and KBW's raised target to $356 add to constructive sentiment — even as Evercore ISI's downgrade to In Line and Barclays' Underweight flag valuation concerns near the 52-week high.

0.7642

July 11, 2026The Travelers Companies edged up modestly on Thursday but is slipping in after-hours trading as a wave of analyst activity weighs on sentiment ahead of its Q2 earnings report due July 17. Evercore ISI downgraded TRV to 'In Line' from 'Outperform' citing valuation constraints, while KBW also cut its rating to 'Market Perform' (though raising its target to $356), contrasting with Truist Securities initiating coverage at 'Buy' with a bullish $395 target. The mixed analyst backdrop comes as TRV trades near its 52-week high of $349.35, with the stock up roughly 32% over the past year, prompting valuation concerns even as Q1 earnings beat estimates ($7.71 EPS vs. $6.80 expected) and the company raised its quarterly dividend to $1.25.

0.4267

July 10, 2026Travelers Companies closed essentially flat as a wave of fresh analyst price target upgrades — including Cantor Fitzgerald raising its target to $360 (Overweight), Wells Fargo lifting to $334, HSBC to $351, and Mizuho to $324 — reinforced confidence in the insurer's fundamentals, even as broader market sentiment was pressured by renewed U.S.-Iran military strikes and surging oil prices reigniting inflation fears. The stock's resilience relative to the broader market reflects its defensive positioning and strong Q1 earnings beat ($7.71 EPS vs. $6.80 est.), a recently raised dividend to $1.25/quarter, and a Seeking Alpha analysis highlighting a ~32% one-year rally grounded in underwriting discipline and premium growth.

-0.1361

July 9, 2026Travelers Companies closed modestly lower as a broad market risk-off selloff, triggered by President Trump declaring the U.S.-Iran ceasefire 'over,' weighed on financial stocks. The financial sector (XLF) also declined sharply amid surging oil prices and renewed inflation fears. Despite the macro headwinds, analyst sentiment remains supportive: UBS raised its price target to $350 (Neutral) and Morgan Stanley lifted its target to $333 (Equal-Weight) on the same day, citing strong personal lines underwriting prospects through 2026–2027. Travelers' recent Q1 beat—EPS of $7.71 vs. $6.80 estimate—and a raised quarterly dividend to $1.25 per share continue to underpin the fundamental case, even as the stock trades above the consensus analyst price target.

-1.6845

MarketBeat · July 17, 2026Travelers Companies Q2 Earnings Call HighlightsBenzinga · July 17, 2026Why Is Travelers Stock Soaring Friday? - Travelers Companies (NYSE:TRV)Benzinga · July 17, 2026Travelers Companies Q2 2026 Earnings Call TranscriptInvesting.com · July 17, 2026Earnings call transcript: Travelers beats Q2 2026 estimates, shares jump 7.4%TradingView · July 17, 2026Travelers Companies Inc reports results for the quarter ended June 30 - Earnings SummaryStockStory · July 17, 2026Travelers (NYSE:TRV) Reports Q2 CY2026 In Line With ExpectationsReuters · July 17, 2026Travelers sails past profit estimates on lower catastrophe lossesSeeking Alpha · July 17, 2026Travelers Q2 earnings exceed consensus on solid underwriting, investment income (TRV:NYSE)
Mt Newswire · July 17, 2026Travelers Reports Surprise Second-Quarter Earnings Growth; Premiums Beat Estimates
Benzinga · July 17, 2026Travelers CEO Refuses to Chase Growth With Price Cuts: 'That's a Fool's Errand'
Benzinga · July 17, 2026Travelers Companies Q2 2026 Earnings Call Transcript
Mt Newswire · July 17, 2026Travelers Q2 Core Income, Revenue Rise
Mt Newswire · July 17, 2026Earnings Flash (TRV) The Travelers Companies, Inc. Posts Q2 Core Income of $10.04 per Share, vs. FactSet Est of $5.41
Mt Newswire · July 17, 2026Earnings Flash (TRV) The Travelers Companies, Inc. Reports Q2 Revenue $12.15B, vs. FactSet Est of $11.26B
Benzinga · July 17, 2026Travelers Companies Q2 Adj. EPS $10.04 Beats $5.38 Estimate, Sales $12.153B Beat $11.346B Estimate
Mt Newswire · July 16, 2026JPMorgan Adjusts Price Target on Travelers Companies to $341 From $322, Maintains Neutral Rating

Peers

S&P 500SPX · $7,490.20-0.58%Chubb LimitedCB · $352.22+2.48%The Allstate CorporationALL · $248.03+2.55%The Progressive CorporationPGR · $207.80+0.97%The Hartford Insurance Group, Inc.HIG · $140.06+2.49%Cincinnati Financial CorporationCINF · $180.96+2.65%Arch Capital Group Ltd.ACGL · $101.54+1.50%AXIS Capital Holdings LimitedAXS · $115.05+1.26%W. R. Berkley CorporationWRB · $71.53+2.33%Kemper CorporationKMPR · $28.21+0.02%Erie Indemnity CompanyERIE · $228.53+1.15%Selective Insurance Group, Inc.SIGI · $96.90+1.75%